    <SEC-DOCUMENT>0001628280-24-012732-index.html : 20240322
    <SEC-HEADER>0001628280-24-012732.hdr.sgml : 20240322
    <ACCEPTANCE-DATETIME>20240322160644
    ACCESSION NUMBER:		0001628280-24-012732
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240322
    DATE AS OF CHANGE:		20240322
    EFFECTIVENESS DATE:		20240322

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
    		CENTRAL INDEX KEY:			0001087294
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				000000000
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-33637
    		FILM NUMBER:		24775237

    	BUSINESS ADDRESS:
    		STREET 1:		2525 WEST END AVENUE
    		STREET 2:		SUITE 950
    		CITY:			NASHVILLE,
    		STATE:			TN
    		ZIP:			37203
    		BUSINESS PHONE:		615-255-0068

    	MAIL ADDRESS:
    		STREET 1:		2525 WEST END AVENUE
    		STREET 2:		SUITE 950
    		CITY:			NASHVILLE
    		STATE:			TN
    		ZIP:			37203
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>a002023_annualreportx0320x.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: a002023_annualreportx0320x.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>